Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Epidemiology/Health Services/Psychosocial Research

Prevalence and Major Risk Factors of Reduced Flow Volume in Lower Extremities With Normal Ankle-Brachial Index in Japanese Patients With Type 2 Diabetes

  1. Eiji Suzuki, MD1,
  2. Katsuya Egawa, MD1,
  3. Yoshihiko Nishio, MD1,
  4. Hiroshi Maegawa, MD1,
  5. Masanobu Tsuchiya, MD1,
  6. Masakazu Haneda, MD1,
  7. Hitoshi Yasuda, MD1,
  8. Shigehiro Morikawa, MD2,
  9. Toshiro Inubushi, PHD2 and
  10. Atsunori Kashiwagi, MD1
  1. 1Department of Medicine, Shiga University of Medical Science, Shiga, Japan
  2. 2Molecular Neurobiology Research Center, Shiga University of Medical Science, Shiga, Japan
    Diabetes Care 2003 Jun; 26(6): 1764-1769. https://doi.org/10.2337/diacare.26.6.1764
    PreviousNext
    • Article
    • Figures & Tables
    • Info & Metrics
    • PDF
    Loading

    Article Figures & Tables

    Figures

    • Tables
    • Figure 1—
      • Download figure
      • Open in new tab
      • Download powerpoint
      Figure 1—

      Distribution of resistive index and total flow volume at the popliteal artery in 176 diabetic patients with normal ABI (non-PAD group). The means ± 2 SD for these parameters in the 33 nondiabetic subjects were defined as the normal range. Abnormal resistive index was thus defined as >1.017 and abnormal total flow volume as <50.8 ml/min. The non-PAD group was classified into normal, borderline, and reduced flow subgroups based on these levels.

    • Figure 2—
      • Download figure
      • Open in new tab
      • Download powerpoint
      Figure 2—

      Waveform analysis at the popliteal artery in 176 diabetic patients with normal ABI (non-PAD). The non-PAD group was divided into normal (A), borderline (B), and reduced (C) flow subgroups based on the resistive index and total flow volume at the popliteal artery. Instantaneous flow volumes at 16 equally spaced time points through the cardiac cycle were reconstructed. Values are expressed as means ± SD.

    Tables

    • Figures
    • Table 1—

      Background data for diabetic patients with normal (non-PAD group) or abnormal (PAD group) ABI and age-matched nondiabetic subjects (control group)

      Control groupNon-PAD groupPAD group
      ABI1.13 ± 0.091.15 ± 0.110.70 ± 0.13
      n3317632
      Sex (male/female)17/16103/73*27/5†
      Age (years)60.1 ± 6.560.9 ± 6.463.6 ± 6.0
      BMI (kg/m2)22.6 ± 2.023.9 ± 3.422.7 ± 3.9
      Duration of diabetes (years)—14.2 ± 8.517.5 ± 10.2
      Treatment (D/OHD/I)—9/67/1002/12/18
      FPG (mmol/l)5.30 ± 0.408.12 ± 2.26‡8.17 ± 2.37‡
      HbA1c (%)4.7 ± 0.48.8 ± 1.7*‡8.1 ± 1.4‡
      TC (mmol/l)4.89 ± 0.625.00 ± 0.904.83 ± 0.80
      HDL cholesterol (mmol/l)1.38 ± 0.421.22 ± 0.371.12 ± 0.30†
      TGs (mmol/l)1.14 ± 0.331.46 ± 0.781.38 ± 0.47
      sBP (mmHg)122 ± 7132 ± 12*‡138 ± 14‡
      dBP (mmHg)76 ± 871 ± 1072 ± 13
      Smokers (%)14 (42)69 (39)§29 (91)†
      CVR-R (%)3.2 ± 1.02.1 ± 1.1‡2.1 ± 0.9‡
      Retinopathy (%)—106 (60)21 (66)
      Nephropathy (%)—83 (47)18 (56)
      • Data are means ± SD or n (%). D, diet; OHD, oral hypoglycemic drugs; I, insulin.

      • †

        ↵† P < 0.05,

      • ‡

        ↵‡ P < 0.001 vs. the control group;

      • *

        ↵* P < 0.05,

      • §

        ↵§ P < 0.01 vs. the PAD group.

    • Table 2—

      Background data for the 176 diabetic patients with normal ABI classified into three subgroups based on resistive index and total flow volume at the popliteal artery

      Normal groupBorderline groupReduced group
      Resistive index0.975 ± 0.0221.038 ± 0.0181.055 ± 0.020
      total flow volume (ml/min)98.8 ± 17.672.5 ± 13.140.4 ± 8.6
      n806333
      Sex (male/female)47/3333/3023/10
      Age (years)60.3 ± 6.461.1 ± 6.561.7 ± 6.2
      BMI (kg/m2)23.9 ± 3.424.3 ± 3.822.7 ± 2.4
      Duration of diabetes (years)13.9 ± 7.714.0 ± 9.415.4 ± 8.8
      Treatment (D/OHD/I)2/35/437/20/360/12/21
      FPG (mmol/l)7.96 ± 1.927.88 ± 2.118.99 ± 3.03
      HbA1c (%)8.9 ± 1.68.7 ± 1.78.9 ± 1.9
      TC (mmol/l)4.97 ± 0.885.11 ± 0.914.87 ± 0.96
      HDL cholesterol (mmol/l)1.16 ± 0.361.27 ± 0.371.25 ± 0.41
      TGs (mmol/l)1.54 ± 0.851.47 ± 0.781.24 ± 0.50
      sBP (mmHg)127 ± 10134 ± 14*138 ± 10†
      dBP (mmHg)70 ± 873 ± 1071 ± 11
      ABI1.16 ± 0.121.16 ± 0.091.12 ± 0.05
      Smokers (%)35 (44)23 (37)11 (33)
      CVR-R (%)2.2 ± 1.22.0 ± 1.12.2 ± 1.2
      Retinopathy (%)41 (51)41 (65)24 (73)
      Nephropathy (%)31 (39)30 (48)22 (67)
      • Data are means ± SD or n (%). D, diet; OHD, oral hypoglycemic drugs; I, insulin. The 80 patients with both normal resistive index and normal flow volume and the 33 patients in whom both these parameters were abnormal are the normal and reduced groups, respectively. The remaining 63 patients comprise the borderline group.

      • *

        ↵* P < 0.01,

      • †

        ↵† P < 0.001 vs. the normal group.

    PreviousNext
    Back to top
    Diabetes Care: 26 (6)

    In this Issue

    June 2003, 26(6)
    • Table of Contents
    • About the Cover
    • Index by Author
    Sign up to receive current issue alerts
    View Selected Citations (0)
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word about Diabetes Care.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Prevalence and Major Risk Factors of Reduced Flow Volume in Lower Extremities With Normal Ankle-Brachial Index in Japanese Patients With Type 2 Diabetes
    (Your Name) has forwarded a page to you from Diabetes Care
    (Your Name) thought you would like to see this page from the Diabetes Care web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Prevalence and Major Risk Factors of Reduced Flow Volume in Lower Extremities With Normal Ankle-Brachial Index in Japanese Patients With Type 2 Diabetes
    Eiji Suzuki, Katsuya Egawa, Yoshihiko Nishio, Hiroshi Maegawa, Masanobu Tsuchiya, Masakazu Haneda, Hitoshi Yasuda, Shigehiro Morikawa, Toshiro Inubushi, Atsunori Kashiwagi
    Diabetes Care Jun 2003, 26 (6) 1764-1769; DOI: 10.2337/diacare.26.6.1764

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Add to Selected Citations
    Share

    Prevalence and Major Risk Factors of Reduced Flow Volume in Lower Extremities With Normal Ankle-Brachial Index in Japanese Patients With Type 2 Diabetes
    Eiji Suzuki, Katsuya Egawa, Yoshihiko Nishio, Hiroshi Maegawa, Masanobu Tsuchiya, Masakazu Haneda, Hitoshi Yasuda, Shigehiro Morikawa, Toshiro Inubushi, Atsunori Kashiwagi
    Diabetes Care Jun 2003, 26 (6) 1764-1769; DOI: 10.2337/diacare.26.6.1764
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • RESEARCH DESIGN AND METHODS
      • RESULTS
      • CONCLUSIONS
      • Acknowledgments
      • Footnotes
      • References
    • Figures & Tables
    • Info & Metrics
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Suboptimal Use of Cardioprotective Drugs in Newly Treated Elderly Individuals With Type 2 Diabetes
    • Disparities in Diabetes Care Between Smokers and Nonsmokers
    • Elevated Cystatin C Concentration and Progression to Pre-Diabetes
    Show more Epidemiology/Health Services/Psychosocial Research

    Similar Articles

    Navigate

    • Current Issue
    • Standards of Care Guidelines
    • Online Ahead of Print
    • Archives
    • Submit
    • Subscribe
    • Email Alerts
    • RSS Feeds

    More Information

    • About the Journal
    • Instructions for Authors
    • Journal Policies
    • Reprints and Permissions
    • Advertising
    • Privacy Policy: ADA Journals
    • Copyright Notice/Public Access Policy
    • Contact Us

    Other ADA Resources

    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • Scientific Sessions Abstracts
    • Standards of Medical Care in Diabetes
    • BMJ Open - Diabetes Research & Care
    • Professional Books
    • Diabetes Forecast

     

    • DiabetesJournals.org
    • Diabetes Core Update
    • ADA's DiabetesPro
    • ADA Member Directory
    • Diabetes.org

    © 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.